Advice for appropriate causal model and analysis method
|
|
13
|
917
|
November 19, 2024
|
Randomized non-comparative trials: an oxymoron?
|
|
16
|
1240
|
October 15, 2024
|
Equipoise lost in RCTs - dropout at random assignment
|
|
5
|
305
|
September 23, 2024
|
Sample Size in crossover trials
|
|
4
|
511
|
August 29, 2024
|
Individual response
|
|
247
|
41841
|
August 21, 2024
|
Modelling correlated and longitudinal complex dataset with mice
|
|
2
|
424
|
July 28, 2024
|
Marginal Structural Models
|
|
2
|
422
|
July 25, 2024
|
Evaluating seizures in open-label studies
|
|
8
|
827
|
July 21, 2024
|
A causal path problem of prediction models
|
|
0
|
809
|
July 1, 2024
|
Missing inclusion criteria data in registry-based studies
|
|
3
|
586
|
May 17, 2024
|
Optimal timing for rescue strategy after repeated failed treatment attempts
|
|
3
|
600
|
April 18, 2024
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
650
|
April 17, 2024
|
Immortal-time-bias vs. selection bias
|
|
2
|
779
|
April 7, 2024
|
Communicating statistical concerns to the FDA
|
|
3
|
848
|
March 11, 2024
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
4131
|
February 16, 2024
|
AIC vs qq-plot for deciding the best model
|
|
2
|
647
|
February 11, 2024
|
Time to pre-randomization monthly seizure count
|
|
1
|
630
|
February 8, 2024
|
Sample Size calculation - "subgroup hypothesis", Guidance needed
|
|
2
|
866
|
February 4, 2024
|
Ranked analysis of ANCOVA
|
|
7
|
2032
|
January 21, 2024
|
BBR Session 7: Study Design, and Crossover Experiment Example
|
|
26
|
11370
|
December 18, 2023
|
Difference in differences
|
|
4
|
1141
|
November 23, 2023
|
Display Forest Plots in SPSS (Meta-Analysis)?
|
|
0
|
788
|
October 25, 2023
|
Best Causal Inference method for repeated Cross-section Design
|
|
1
|
1093
|
October 5, 2023
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
943
|
September 4, 2023
|
Interim Analysis Plan for Observational Studies
|
|
3
|
1581
|
August 16, 2023
|
Survival analysis vs. nested case-control analysis
|
|
3
|
1463
|
August 14, 2023
|
External validation or a bigger modelling sample?
|
|
9
|
1953
|
August 12, 2023
|
Design of Experiments in Economics vs Medicine: a Decision Theory POV
|
|
6
|
2222
|
July 27, 2023
|
Strategies to overcome referral \ workup bias in Diagnosis Prediction Models
|
|
8
|
1025
|
July 24, 2023
|
Design ideas for non-inferiority trials were event rates are low
|
|
8
|
2460
|
May 21, 2023
|